Outlook 2024
Annual Industry Ranking And Forecast
VIEW NOWHBW Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Printed By
Views from industry leaders and experts on the biggest trends, challenges and opportunities facing consumer health in the new year.
Masimo receives US regulatory clearance for Stork OTC baby monitoring system six months after Owlet received first clearance for the type of product following a regulatory stumble which halted sales of a previous device in 2021.
Infirst gets rapped by UK ad authority, ASA, for implying its lipid-based ibuprofen brand Flarin is more effective than other ibuprofen products. The lesson: think about whether any emphasis given to certain words within a claim, or whether the positioning of a claim within an ad, is likely to affect the overall take-home message, advises Advercheck.
“I Am Sweating But Nothing On My Armpits!” and other no-sweat advertising claims made for Unilever’s Degree Advanced 72H antiperspirant products were challenged by P&G in the National Advertising Division forum.
Vitamin Shoppe announces Whole Health Rx telehealth services offering supplements for GLP-1 patients and access to doctors for prescribing the drugs a week after GNC said it was “first major retailer to establish an entire section dedicated to assisting GLP-1 users.”
Vitamin Shoppe announces Whole Health Rx telehealth services offering supplements for GLP-1 patients and access to doctors for prescribing the drugs a week after GNC said it was “first major retailer to establish an entire section dedicated to assisting GLP-1 users.”
Direct seller reports Q1 sales up 1% to $1.3bn but net sales off 17.1% from year-ago period to $24.3m. Its distributor ranks jumped so far in 2024, particularly in China, where changes were made in the past year including new company leadership.
The Estee Lauder Companies’ expanding use of artificial intelligence includes an internal-facing generative AI chatbot to help users “efficiently navigate and further leverage ELC's proprietary and extensive database of product and claim data.” Meanwhile, Prose Beauty is leveraging AI to market personalized skin and hair products at scale, and Vagaro to provide salons and spas with “instantly crafting polished communications, such as service and policy descriptions, effective marketing messaging, and more.”
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
In this episode of the updated Over The Counter podcast, HBW Insight speaks to sustainable packaging expert Tony Perrotta about the complexities of replacing plastic pill packs in medicines packaging. Perrotta is a partner at PA Consulting, which set up the Blister Pack Collective alongside consumer health players Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the Collective hopes to commercialize within 12-24 months. We discuss whether regulators will accept such alternatives, given the safety and stability requirements for medicines, and the challenges of recycling, given the multitude of different frameworks and processes across the world. Perrotta also reveals that one of the partners in PA Consulting’s Bottle Collective, which hopes to replace plastic bottles in the food, personal care and consumer health industries, will soon launch its first market trial.
Cataloging materials by category across US states or even internationally, chasing down information from supply partners, and other aspects of extended producer responsibility (EPR) program compliance can be a lot easier in collaboration with a software solutions vendor or other third party, says Michael Washburn, principal at Washburn Consulting.
London-based Unilever is resetting targets including virgin plastic reductions and increases in packaging that is recyclable, reusable or compostable. Based on a report last year from the Ellen MacArthur Foundation on industry progress against goals to reduce plastic waste, Unilever will not be alone in having to recalibrate.
Thousands of companies operating within the EU will soon be required to identify across their whole supply chain any adverse impact on the environment and human rights. Failure to do so could mean fines of up to 5% of worldwide net sales.
In this episode of the updated Over The Counter podcast, HBW Insight speaks to sustainable packaging expert Tony Perrotta about the complexities of replacing plastic pill packs in medicines packaging. Perrotta is a partner at PA Consulting, which set up the Blister Pack Collective alongside consumer health players Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the Collective hopes to commercialize within 12-24 months. We discuss whether regulators will accept such alternatives, given the safety and stability requirements for medicines, and the challenges of recycling, given the multitude of different frameworks and processes across the world. Perrotta also reveals that one of the partners in PA Consulting’s Bottle Collective, which hopes to replace plastic bottles in the food, personal care and consumer health industries, will soon launch its first market trial.
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
“Consumers are rewriting the rules when it comes to where they are going for information and the type of information they are looking for,” reports Kaizo’s Anita Nahal, speaking to HBW Insight’s Over the Counter podcast about the agency’s latest Communicating Health Messages report. Trust in social media has increased, and personal beliefs and lived experiences are playing a larger role in shaping attitudes to health information, explains Nahal, who is director at the London-based PR agency. However, consumers are also continuing to “tune-out” from health messages and be less critical of sources. To help consumers navigate this new reality, consumer health companies need to adapt, rethink and reset their communication strategies, Nahal advises.
There’s no simple answer to the question of how to make medicines packaging sustainable, says international recycling consultancy and Veolia Group subsidiary Circpack. “Manufacturers need to assess what works best for them, and recyclers will do the same,” Circpack analyst and circular packaging expert Filipe Vieira de Castro tells HBW Insight in this exclusive Q&A. “The best thing we can all do is put effort into finding common ground between systems, which comes down to better understanding the complexities between them.”
Masimo receives US regulatory clearance for Stork OTC baby monitoring system six months after Owlet received first clearance for the type of product following a regulatory stumble which halted sales of a previous device in 2021.
Infirst gets rapped by UK ad authority, ASA, for implying its lipid-based ibuprofen brand Flarin is more effective than other ibuprofen products. The lesson: think about whether any emphasis given to certain words within a claim, or whether the positioning of a claim within an ad, is likely to affect the overall take-home message, advises Advercheck.
“I Am Sweating But Nothing On My Armpits!” and other no-sweat advertising claims made for Unilever’s Degree Advanced 72H antiperspirant products were challenged by P&G in the National Advertising Division forum.
Vitamin Shoppe announces Whole Health Rx telehealth services offering supplements for GLP-1 patients and access to doctors for prescribing the drugs a week after GNC said it was “first major retailer to establish an entire section dedicated to assisting GLP-1 users.”
Prices are expected to continue rising for dietary supplements containing marine lipids due to a worldwide shortage of fish oil, according to ingredients firm DSM-Firmenich.
In this episode of the updated Over The Counter podcast, HBW Insight speaks to sustainable packaging expert Tony Perrotta about the complexities of replacing plastic pill packs in medicines packaging. Perrotta is a partner at PA Consulting, which set up the Blister Pack Collective alongside consumer health players Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the Collective hopes to commercialize within 12-24 months. We discuss whether regulators will accept such alternatives, given the safety and stability requirements for medicines, and the challenges of recycling, given the multitude of different frameworks and processes across the world. Perrotta also reveals that one of the partners in PA Consulting’s Bottle Collective, which hopes to replace plastic bottles in the food, personal care and consumer health industries, will soon launch its first market trial.
On the wings of innovation and a new host of influencers, Coty says CoverGirl ranked number three in the US in earned media value among its peer set in the third quarter ended 31 March, versus sixth in the same period last year. CEO Sue Nabi had more to say about the firm’s social media “step-changing” in her remarks on Q3 results.
Perrigo spares little about Opill’s launch, advertising and outlook in Q1 earnings briefing, but management also makes clear it’s a large firm and some other segments of its global consumer health products business are holding back overall results.
Along with latest results, Kenvue says as its “transitions services agreement” with J&J ends, its board approves reducing global workforce by around 4%. It expects around $275m in pre-tax restructuring costs in both 2024 and 2025 without changes to its capital allocation priorities.
The Association of the European Self-Care Industry gives EU regulators a to-do list of targeted reforms to save the Medical Devices Regulation from the scrapheap.
Compliance functions will be moved to the product centers when ORA becomes the Office of Inspections and Investigations, and centers will become responsible for making the final agency decision on inspection classifications, Associate Commissioner Michael Rogers said.
Without additional funding, FDA’s ORA faces challenges in retaining and hiring staff, which will impact inspections, says office chief Michael Rogers.
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.